UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

0.1% bupivacaine does not reduce the requirement for epidural fentanyl infusion after major abdominal surgery

Regional anesthesia, 1995-09, Vol.20 (5), p.435

1995

Volltextzugriff (PDF)

1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors

Cancer chemotherapy reports. Part 1, 1972-12, Vol.56 (6), p.751

1972

Volltextzugriff (PDF)

1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors

Cancer chemotherapy reports. Part 1, 1970-08, Vol.54 (4), p.273

1970

Volltextzugriff (PDF)

1 year's use of alizapride for the prevention and treatment of nausea and vomiting secondary to anticancer agents

Annales de gastroenterologie et d'hepatologie, 1985-01, Vol.21 (1), p.53

Olivier, J P

1985

Volltextzugriff (PDF)

A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorder

International clinical psychopharmacology, 2013-07, Vol.28 (4), p.206

2013

Volltextzugriff (PDF)

10 years of L-DOPA therapy of Parkinson's syndrome

Wiener Klinische Wochenschrift, 1971-04, Vol.83 (13), p.221

Birkmayer, W

1971

Volltextzugriff (PDF)

15-hydroxystearate micelles for the delivery of aprepitant: Preparation, characterization, pharmacokinetics and tissue distribution in mice

Pakistan journal of pharmaceutical sciences, 2021-03, Vol.34 (2), p.635-639

2021

Volltextzugriff (PDF)

A 15-year-old with blurred vision, nausea, back pain, and abdominal pain

Journal of emergency nursing, 2003-04, Vol.29 (2), p.171-173

Kuensting, Laura L.

2003

Volltextzugriff (PDF)

17 AAG for HSP90 inhibition in cancer--from bench to bedside

Current molecular medicine, 2009-06, Vol.9 (5), p.654-664

2009

Volltextzugriff (PDF)

17th World Congress on Gastrointestinal Cancers

The Lancet. Oncology, 2015-08, Vol.16 (8), p.890-890

Brierley, Rob

2015

Volltextzugriff (PDF)

First Clinical Trial with Iohexol in Myelography

Acta Radiologica. Diagnosis, 1983-01, Vol.24 (6), p.499-502

1983

Volltextzugriff (PDF)

1st experiences in the treatment of ovarian tumors with Peptichemio

Minerva medica, 1974-05, Vol.65 (33), p.1805

1974

Volltextzugriff (PDF)

2,4-D poisoning

Medycyna pracy, 1978, Vol.29 (1), p.61

1978

Volltextzugriff (PDF)

2 alpha, 3 alpha-epithio-5 alpha-androstan-17 beta-OL in the treatment of chronic mastopathy

Endocrinologia japonica, 1968-09, Vol.15 (3), p.371

1968

Volltextzugriff (PDF)

2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster

The Journal of infectious diseases, 1986-09, Vol.154 (3), p.430-436

1986

Volltextzugriff (PDF)

2 oral contraceptives with the same gestagen and different estrogen. A controlled clinical trial

Ugeskrift for læger, 1975-01, Vol.137 (3), p.145

1975

Volltextzugriff (PDF)

A 2013 updated systematic review & meta-analysis of 36 randomized controlled trials; no apparent effects of non steroidal anti-inflammatory agents on the risk of bleeding after tonsillectomy

Clinical otolaryngology, 2013-04, Vol.38 (2), p.115-129

2013

Volltextzugriff (PDF)

2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy

Supportive care in cancer, 2017, Vol.25 (1), p.317-321

2017

Volltextzugriff (PDF)

2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential

Supportive care in cancer, 2017, Vol.25 (1), p.297-301

2017

Volltextzugriff (PDF)

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents

Supportive care in cancer, 2017-01, Vol.25 (1), p.271-275

2017

Volltextzugriff (PDF)

2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer

Supportive care in cancer, 2017, Vol.25 (1), p.333-340

2017

Volltextzugriff (PDF)

2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children

Supportive care in cancer, 2017, Vol.25 (1), p.323-331

2017

Volltextzugriff (PDF)

2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy

Supportive care in cancer, 2017, Vol.25 (1), p.289-294

2017

Volltextzugriff (PDF)

2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting

Supportive care in cancer, 2017-01, Vol.25 (1), p.303-308

2017

Volltextzugriff (PDF)

2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients

Supportive care in cancer, 2024-05, Vol.32 (5), p.280-280, Article 280

2024

Volltextzugriff (PDF)

1 – 25 von 9.967

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8.544)
Mit Volltextzugriff
(6.373)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(9.741)
Nausea - Chemically Induced
(8.485)
Science & Technology
(7.200)
Life Sciences & Biomedicine
(7.155)
Female
(6.577)
Male
(5.474)
Vomiting - Chemically Induced
(5.140)
Adult
(5.048)
Middle Aged
(5.003)
Aged
(3.750)
Oncology
(2.636)
Biological And Medical Sciences
(2.578)
Medical Sciences
(2.517)
Antineoplastic Agents - Adverse Effects
(2.205)
Nausea
(1.986)
Pharmacology. Drug Treatments
(1.857)
Chemotherapy
(1.639)
Antiemetics - Therapeutic Use
(1.626)
Nausea - Prevention & Control
(1.589)
Treatment Outcome
(1.588)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(9.961)
LWW Total
(4.436)
IngentaConnect
(4.091)
Free E-Journal (出版社公開部分のみ）
(3.242)
Publisher or Other Site
(2.477)
IngentaConnect Journals
(1.872)
Wiley-Blackwell Journals
(1.406)
Springer LINK
(1.369)
Elsevier ScienceDirect Journals Complete
(1.316)
Wiley Online Library
(1.031)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(957)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(910)
Taylor & Francis Journals
(410)
Taylor & Francis
(355)
Taylor & Francis Current Content Access
(351)
SAGE Journals
(318)
BMJ
(267)
Oxford Journals Online Current
(265)
Oxford Journals 2020 Medicine
(216)
SpringerLink Series
(207)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Supportive Care In Cancer
(349)
Gan To Kagaku Ryoho
(311)
Journal Of Clinical Oncology
(217)
Cancer
(187)
Cancer Chemotherapy And Pharmacology
(139)
Cancer Treatment Reports
(139)
Anesthesia And Analgesia
(129)
Bmj
(111)
American Journal Of Clinical Oncology
(110)
European Journal Of Cancer
(109)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

0.1% bupivacaine does not reduce the requirement for epidural fentanyl infusion after major abdominal surgery

1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors

1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors

1 year's use of alizapride for the prevention and treatment of nausea and vomiting secondary to anticancer agents

A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorder

10 years of L-DOPA therapy of Parkinson's syndrome

15-hydroxystearate micelles for the delivery of aprepitant: Preparation, characterization, pharmacokinetics and tissue distribution in mice

A 15-year-old with blurred vision, nausea, back pain, and abdominal pain

17 AAG for HSP90 inhibition in cancer--from bench to bedside

17th World Congress on Gastrointestinal Cancers

First Clinical Trial with Iohexol in Myelography

1st experiences in the treatment of ovarian tumors with Peptichemio

2,4-D poisoning

2 alpha, 3 alpha-epithio-5 alpha-androstan-17 beta-OL in the treatment of chronic mastopathy

2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster

2 oral contraceptives with the same gestagen and different estrogen. A controlled clinical trial

A 2013 updated systematic review & meta-analysis of 36 randomized controlled trials; no apparent effects of non steroidal anti-inflammatory agents on the risk of bleeding after tonsillectomy

2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy

2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents

2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer

2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children

2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy

2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting

2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients

Suchergebnisse filtern